Added text to state that an updated review published in 2016 found limited evidence that skin cancer screening reduces melanoma mortality (cited Wernli et al. as reference 21 and Bibbins-Domingo et al. as reference 22).
Added text to state that no randomized trials evaluating the efficacy of skin cancer screening on mortality have been completed. Also revised text to state that a population-based trial to determine the effect of skin cancer screening on melanoma mortality was initiated in Queensland, Australia, and no health outcomes were ever reported (cited Aitken et al. as reference 23).
Added text to state that the highest level of direct evidence available is an ecologic study comparing melanoma mortality rates across different regions of northern Germany (the SCREEN study). Also revised text to describe the screening interventions provided in one region that conducted a population-based skin cancer awareness campaign from the SCREEN study. Also revised text to add that there was about one fewer melanoma death per 100,000 screened participants in the years after the screening program in the screened region. Also revised text to add that low participation rate and high loss to follow-up rate were important methodological limitations of the SCREEN study. Also added that an independent analysis of the SCREEN study population found that the observed modest mortality reduction did not persist with longer-term follow-up (cited Boniol et al. as reference 26).
Revised text to state that harms have not been well studied or reported in quantitative terms, but the potential for adverse consequences from skin cancer screening exists. Also added text to describe the findings from the SCREEN study, including the rate of skin excision of all screened participants. Also added that one case of melanoma was detected per 28 excisions overall (for both men and women), while 52 skin excisions were required to detect one melanoma in men aged 20 to 34 years (cited Waldmann et al. as reference 27).
ver historia personal en: www.cerasale.com.ar [dado de baja por la Cancillería Argentina por temas políticos, propio de la censura que rige en nuestro medio]//
weblog.maimonides.edu/farmacia/archives/UM_Informe_Autoevaluacion_FyB.pdf - //
weblog.maimonides.edu/farmacia/archives/0216_Admin_FarmEcon.pdf - //
www.proz.com/kudoz/english_to_spanish/art_literary/523942-key_factors.html - 65k - // www.llave.connmed.com.ar/portalnoticias_vernoticia.php?codigonoticia=17715 // www.frusculleda.com.ar/homepage/espanol/activities_teaching.htm // http://www.on24.com.ar/nota.aspx?idNot=36331 ||